Investors seeking opportunities in the healthcare sector may find 10x Genomics, Inc. (NASDAQ: TXG) an intriguing option. Despite its current challenges, the company presents a notable 28.08% potential upside based..
Pulse Biosciences, Inc. (NASDAQ: PLSE), a formidable player in the healthcare sector, is making waves in the medical instruments and supplies industry with its pioneering bioelectric medicine technologies. Headquartered in..
89bio, Inc. (NASDAQ: ETNB), a promising player in the biotechnology sector, has caught the attention of investors with its ambitious approach to addressing liver and cardio-metabolic diseases. Specializing in the..
Novavax, Inc. (NASDAQ: NVAX), a prominent player in the biotechnology sector, is captivating investor attention with its substantial growth potential. The company, based in Gaithersburg, Maryland, specializes in the development..
Ocular Therapeutix, Inc. (NASDAQ: OCUL), a notable player in the biotechnology sector, stands out with a remarkable potential upside of 95.69% based on current analyst ratings. As a biopharmaceutical company..
Immunocore Holdings plc (NASDAQ: IMCR), a pioneering biotechnology company based in the United Kingdom, is capturing attention with its promising portfolio of immunotherapies targeting cancer, infectious diseases, and autoimmune disorders...
Viking Therapeutics, Inc. (NASDAQ: VKTX), a clinical-stage biopharmaceutical company, has been capturing the attention of investors with its compelling pipeline of novel therapies aimed at treating metabolic and endocrine disorders...
Innoviva, Inc. (NASDAQ: INVA) stands out as a noteworthy player in the healthcare sector, particularly within the biotechnology industry. With a market capitalization of $1.35 billion, this U.S.-based company has..
GRAIL, Inc. (NASDAQ: GRAL) is making waves in the healthcare industry with its innovative approach to cancer diagnostics. Specializing in multi-cancer early detection testing, GRAIL is positioned at the forefront..
Belite Bio, Inc (BLTE) stands out in the competitive biotechnology sector with its innovative approach to tackling unmet medical needs in retinal degenerative diseases. With a market capitalization of $2..
GoodRx Holdings, Inc. (NASDAQ: GDRX) stands as a significant player in the healthcare sector, specifically within the health information services industry. With its innovative platform offering consumers the ability to..
Dyne Therapeutics, Inc. (NASDAQ: DYN) is currently a standout in the biotechnology sector, captivating investor interest with a remarkable potential upside of 211.57%. Headquartered in Waltham, Massachusetts, Dyne is at..
ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) is capturing the attention of investors with its promising outlook in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. With a..
UFP Technologies, Inc. (NASDAQ: UFPT), a key player in the healthcare sector, particularly within the medical device industry, presents an intriguing opportunity for investors seeking growth in a niche market...
Warby Parker Inc. (NYSE: WRBY), a key player in the Healthcare sector’s Medical Instruments & Supplies industry, continues to capture investor attention with its innovative approach to eyewear. With a..
AdaptHealth Corp. (NASDAQ: AHCO), a prominent player in the healthcare sector, operates within the medical devices industry, providing essential home medical equipment and services across the United States. Headquartered in..
Adaptive Biotechnologies Corporation (NASDAQ: ADPT) is garnering attention in the biotech sector, particularly due to its impressive 25.2% revenue growth and a strong consensus from analysts. With a market cap..
For investors seeking opportunities in the healthcare sector, Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) presents a compelling case for consideration. As a global biopharmaceutical company, Amneal specializes in the development, manufacturing,..
Apellis Pharmaceuticals, Inc. (NASDAQ: APLS), a prominent name in the biotechnology sector, has captured investor attention with its high potential upside of 86.95%, as indicated by current analyst ratings. This..
Arcellx, Inc. (NASDAQ: ACLX), a promising player in the biotechnology sector, is capturing the attention of growth-oriented investors due to its potential upside of 66.34%. With its current stock price..
